Abstract | OBJECTIVE: Although uterine leiomyomas are the most common gynaecological benign tumour and greatly affect reproductive health and well being, the pathophysiology and epidemiology of uterine leiomyomas are not well known. Elevated blood pressure has an independent, positive association with risk for clinically detected uterine leiomyomas. Aldosterone is a key biological peptide in the renin-angiotensin-aldosterone system that regulates blood pressure. In this study, we investigated the siginificant stimulatory effect of aldosterone on leiomyoma cells proliferation. STUDY DESIGN: This study investigated the potential role of aldosterone in the proliferation of ELT-3 leiomyoma cells. RESULTS: CONCLUSION: These experimental findings in vitro show the presence of complex regulation of Ang II and aldosterone induced leiomyoma cell proliferation.
|
Authors | Aki Isobe, Takashi Takeda, Atsuko Wakabayashi, Kenji Tsuiji, Bin Li, Masahiro Sakata, Nobuo Yaegashi, Tadashi Kimura |
Journal | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
(Gynecol Endocrinol)
Vol. 26
Issue 5
Pg. 372-7
(May 2010)
ISSN: 1473-0766 [Electronic] England |
PMID | 20050763
(Publication Type: Journal Article)
|
Chemical References |
- Angiotensin II Type 1 Receptor Blockers
- RNA, Messenger
- Receptor, Angiotensin, Type 1
- Receptors, Mineralocorticoid
- Angiotensin II
- Spironolactone
- Aldosterone
- RNA
|
Topics |
- Aldosterone
(pharmacology)
- Angiotensin II
(antagonists & inhibitors, pharmacology)
- Angiotensin II Type 1 Receptor Blockers
- Animals
- Cell Division
(drug effects)
- Cell Line, Tumor
- Female
- Gene Expression
- Leiomyoma
(chemistry, pathology)
- RNA
(analysis)
- RNA, Messenger
(analysis)
- Rats
- Receptor, Angiotensin, Type 1
(genetics)
- Receptors, Mineralocorticoid
(genetics)
- Reverse Transcriptase Polymerase Chain Reaction
- Spironolactone
(pharmacology)
- Up-Regulation
(drug effects)
- Uterine Neoplasms
(chemistry, pathology)
|